AstraZeneca's dynamic duo wants to dominate in cancer drugs - STAT

1. AstraZeneca's dynamic duo wants to dominate in cancer drugs  STAT
2. Pancreatic cancer therapy sheds light on the disease's ties to BRCA mutation  CNN
3. ASCO: AZ, Merck's Lynparza fends off pancreatic cancer, cutting progression risk in half  FiercePharma
4. New drug therapy slows spread of pancreatic cancer: study  St. Lucia News Online
5. Lynparza stalls pancreatic cancer in patients with BRCA mutations: study  CNA
6. View full coverage on Google News

 
by via Top stories - Google News